Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors
Munster et al • 2022 • Clin Cancer Res OF1–OF11
Munster et al • 2022 • Clin Cancer Res OF1–OF11
Colombo et al • 2022 • American Society of Clinical Oncology Annual Meeting
Borazanci et al • 2022 • American Society of Clinical Oncology Annual Meeting
Lorusso et al. • 2021 • European Society for Medical Oncology (ESMO) Congress 2021
Greenstein et al. • 2021 • Oncotarget . 2021 Jun 22;12(13):1243-1255. doi: 10.18632/oncotarget.27989.
Greenstein et al. • 2021 • Endocr Relat Cancer . 2021 Jun 29;28(8):583-592. doi: 10.1530/ERC-21-0048.
Greenstein et al. • 2020 • AACR Annual Meeting 2020
Greenstein et al. • 2020 • Citation: J Clin Oncol 38: 2020 (suppl; abstract #: 3091)
Munster et al. • 2019 •
Kach et al. • 2017 • Mol Cancer Ther. 2017;16(8):1680-1692.